BridgeBio Pharma BBIO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$166.56M+1.8% | -$194.64M+27.2% | -$184.94M-12.6% | -$183.76M-143% | -$169.61M-369% | ||
| $1.19M-7.6% | $1.44M+5.0% | $1.4M-9.1% | $1.32M-16.3% | $1.28M-19.5% | ||
| $33.24M+28.4% | $34.64M+15.0% | $35.26M+29.8% | $37.24M+73.6% | $25.88M+51.7% | ||
| -$197.28M+1.0% | -$56.42M+71.1% | -$109.57M+39.3% | -$80.68M— | -$199.24M+9.2% | ||
| $69K— | $33K-29.8% | $470K+243% | $594K+1,000% | $0-100% | ||
| -$42.74M-2,579% | -$14.35M— | —— | -$13M-528% | -$1.6M-107% | ||
| $82.5M+70.9% | —— | —— | —— | $48.28M— | ||
| —— | —— | —— | —— | —— | ||
| $0-100% | —— | —— | —— | $459M-3.0% | ||
| $549.89M+812% | —— | —— | $302.04M— | $60.33M-78.4% | ||
| $309.88M+321% | -$72.96M-126% | -$106M— | $208.36M+189% | -$140.5M-270% | ||
| -$197.35M+0.9% | -$56.45M+71.1% | -$110.04M+39.1% | -$81.28M— | -$199.24M+9.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BridgeBio Pharma generate?
- BridgeBio Pharma (BBIO) generated -$444.0M in operating cash flow over the trailing twelve months.
- What is BridgeBio Pharma's free cash flow?
- After $1.2M of capital expenditures, BridgeBio Pharma's free cash flow was -$445.1M over the trailing twelve months, up 44.0% year over year.
- Where does BridgeBio Pharma's cash flow data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
